GWGuo-Sheng Wang

Guo-Sheng Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guo-Sheng Wang has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Integrative spatial multiomics analysis reveals regulatory mechanisms of VCAM1+ proximal tubule cells in lupus nephritis

    by Junyu Wang, Ao Zheng, Nianping Liu, Zhen Tan, Yu Shi, Tianyi Ma, Songwen Luo, Lin Zhu, Zhou Zhou, Feifei Yuan, et al.


    • 1 November 2013
      • Vol. 52  (11) , 928-31

    [Peptidyl arginine deiminase 4 participates in the pathogenesis of rheumatoid arthritis by influencing histone methylation].

    by Jing Guo, Long Qian, Xiang-Pei Li, Xiao-Mei Li, Guo-Sheng Wang, Xuan Fang

    To explore the probable function of peptidyl arginine deiminase 4 (PAD4) in rheumatoid arthritis(RA). Real-time quantitative polymerase chain reaction (PCR) was used to determine the expression of PAD4 mRNA in peripheral blood mononucleated cells (PBMCs) from 60 RA patients and 40 healthy individuals. Asymmetric di-methylation of histone H3R17, symmetric di-methylation and mono-methylation of H4R3 were semi-quantified by Western blotting in 12 patients with osteoarthritis (OA), 26 patients with RA and 10 healthy controls. PAD4 mRNA in RA was significantly higher than that in healthy controls[34.6(16.7, 70.8) vs 20.6(11.1, 51.8), P < 0.05]. The level of histone H3R17 asymmetric di-methylation in RA was significantly higher than that of OA or control groups (71.34 ± 25.65 vs 37.18 ± 18.62 vs 50.67 ± 13.99, P < 0.01) , which was positively related to Tender joint count and Swollen joint count in 28 joints (r = 0.418, P = 0.034;r = 0.402, P = 0.042). The level of histone H4R3 symmetric di-methylation was similar in RA,OA and control groups (75.02 ± 20.35 vs 57.92 ± 22.77 vs 68.37 ± 17.57, P > 0.05) . The level of histone H4R3 mono-methylation in RA patients was significantly lower than that of OA patients and healthy individuals (11.24 ± 7.81 vs 32.77 ± 30.77 vs 51.20 ± 47.14, P < 0.05). The level of histone H4R3 mono-methylation in RA patients was negatively correlated to PAD4 (r = -0.643, P < 0.01) . The level of histone H3R17 asymmetric di-methylation and H4R3 symmetric di-methylation was not associated with PAD4 level in RA group (r = -0.185, P = 0.377; r = 0.198, P = 0.344). The level of histone H3R17 asymmetric di-methylation is significantly higher and the level of histone H4R3 mono-methylation is significantly lower in RA patients comparing with OA and control groups. Abnormality of histone methylation may be one of the mechanisms for the development of RA. PAD4 probably plays an important role in rheumatoid arthritis by influencing histone methylation.

    • 22 October 2013
      • Vol. 93  (39) , 3119-21

    [Activation of hypomethylated DNA on plasmacytoid dendritic cells in patients with systemic lupus erythematosus].

    by Jing-Jing Zhou, Guo-Sheng Wang, Xiang-Pei Li, Xiao-Mei Li, Long Qian

    To explore the activation of hypomethylated DNA on plasmacytoid dendritic cells (pDC) in patients with systemic lupus erythematosus (SLE). Peripheral blood mononuclear cells (PBMC) were isolated from whole blood of SLE patients and healthy controls. The methylation level of DNA and the expression of DNA methyltransferase 1 (DNMT1) mRNA were detected. Flow cytometry was used to detect the expression of CD32 on pDC and the serum concentration of interferon-alpha (IFN-α) measured by enzyme-linked immunosorbent assay (ELISA). The DNA methylation level from SLE patients (1.4 ± 0.6) % was lower than that of controls (1.8 ± 0.7) % (P < 0.01). The expression of DNMT1 mRNA significantly decreased in SLE patients (0.06 ± 0.03) versus the controls (0.09 ± 0.02) (P < 0.01). The CD32 expression on pDC from SLE patients (29 ± 19)% was higher than that from controls (18.02 ± 7.80)% (P < 0.01). The serum level of IFN-α in SLE patients (4.5 ± 6.7) ng/L was significantly higher than that of controls (2.1 ± 2.0) ng/L (P < 0.01). The methylation level of DNA in SLE patients was positively correlated with the expression of DNMT1 mRNA (r = 0.257, P < 0.05) and negatively with the expression of CD32 (r = -0.358, P < 0.01) and IFN-α (r = -0.280, P < 0.05). The methylation level of genomic DNA decreases in SLE patients due to the down-regulated expression of DNMT1 gene. Hypomethylated DNA may be translocated intracellularly via endocytic receptor (CD32) on pDC. And the activation of pDC is induced to produce IFN-α so as to participate in the onset of SLE.


    • 20 August 2013
      • Vol. 93  (31) , 2483-6

    [Role of transcription factor ETS-1 and B cell in the pathogenesis of systemic lupus erythematosus].

    by Qi-Jie Ren, Xiang-Pei Li, Jin-Hui Tao, Ning Yu, Xiao-Mei Li, Guo-Sheng Wang, Hong Zhang, Xuan Fang

    To explore the effects of transcription factor ETS-1 mRNA and B lymphocyte-associated cytokines on the differentiation of B cells in systemic lupus erythematosus (SLE) patients and explore its pathogenic and clinical significance. Thirty-one SLE patients (20 active and 11 inactive) and 15 healthy controls were enrolled. CD19+ B cells were isolated with magnetic beads. The levels of ETS-1 mRNA in B cells were determined by real-time polymerase chain reaction (PCR). Flow cytometry was used to detect the altered ratio of CD19-CD138 + plasma cells and CD19 + B cells. And enzyme-linked immunosorbent assay (ELISA) was performed to detect the serum levels of B cell differentiation-related cytokines interleukin-10 (IL-10) and APRIL. Compared to the healthy controls, SLE patients showed decreased mRNA expression level of ETS-1 in B cells (Z = -4.218, P < 0.01) . Moreover, the expression level of ETS-1 mRNA was significantly negatively correlated with the proportion of CD19-CD138+ plasma cells (r = -0.359, P < 0.05) and negatively correlated with the CD19-CD138 +B cells/CD19+ plasma cells ratio (r = -0.493, P < 0.01) . However, there was no correlation in normal controls. Significant negative correlation existed between the expression level of ETS-1 mRNA in B cells and the serum levels of IL-10 and APRIL in active SLE patients. But no correlation existed in inactive group. ETS-1 may participate in the pathogenesis of SLE through its effects on the differentiation of B cells and cooperation with IL-10 and APRIL.

    • 4 September 2012
      • Vol. 92  (33) , 2335-8

    [Predictive factors and unfavorable prognostic factorial analysis of interstitial lung disease in patients with inflammatory myopathy].

    by Ran Li, Xiang-Pei Li, Xiao-Mei Li, Guo-Sheng Wang, Long Qian, Jin-Hui Tao, Yan Ma, Hong Zhang

    To explore the clinical features, predictive factors and unfavourable prognostic factors of interstitial lung disease (ILD) in the patients with polymyositis and dermatomyositis (PM/DM) so as to provide rationales for early clinical diagnosis and treatment. The medical records of 244 PM/DM patients from Department of Rheumatology & Immunology of Anhui Medical University Affiliated Provincial Hospital from August 2001 to August 2011 were reviewed to analyze the clinical features, predictive factors and unfavourable prognostic factors of ILD in PM/DM patients. The major clinical manifestations of PM/DM-ILD included dry cough, chest tightness and shortness of breath during activities and Velcro rale in lower lung. Besides anti-Jo-1 antibody, multivariate unconditional Logistic regression analysis indicated that amyopathic dermatomyositis (ADM), arthralgia/arthritis, fever and Gottron's sign were the predictive factors for the development of ILD in PM/DM patients. ADM and Hamman-Rich-like pattern ILD were the poor prognostic factors while large dose glucocorticoids plus immunosuppressant therapy in the early time was a protective factor for PM/DM-ILD patients. Some clinical features are the predictive factors for the development of ILD. ADM and Hamman-Rich-like pattern ILD are poor prognostic factors. Large dose glucocorticoids plus immunosuppressant therapy can significantly improve the prognosis of PM/DM patients.

    • 1 February 2011
      • Vol. 50  (2) , 107-10

    [The significance of serum peptidylarginine deiminase 4 in rheumatoid arthritis].

    by Long Qian, Heng-Xing Shi, Xiang-Pei Li, Hong Zhang, Xiao-Mei Li, Guo-Sheng Wang

    To detect the levels of serum peptidylarginine deiminase (PADI)4 and explore its significance in rheumatoid arthritis (RA). The presence of PADI4, anti-PADI4 antibodies and anti-cyclic citrullinated peptide (CCP) antibodies levels were examined by enzyme-linked immunosorbent assay (ELISA). Serum samples were obtained from 100 patients with RA, 23 patients with other rheumatic diseases, and 24 healthy controls. The associations between PADI4 and the disease activity score using 28 joint counts (DAS28) score, anti-CCP antibodies, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), PADI4-94 (rs 2240340) and PADI-104 (rs 1748033) gene polymorphisms and other indexes were analyzed in RA. The levels of PADI4 in RA patients were significantly higher than in other rheumatic diseases and healthy controls (F = 8.75, P < 0.001). There was no significantly difference in levels of PADI4 among ADI4-94 (rs 2240340)/PADI-104 (rs 1748033) genotypes. PADI4 is associated with disease activity involved in the RA pathogenesis and may be a RA pathogenic antigen.


    • 16 June 2009
      • Vol. 89  (23) , 1636-8

    [Expression of FOXP3 in CD4+ CD39+ T cells of patients with systemic lupus erythematosus and dynamic observation of treatment with glucocorticoid].

    by Dong-Mei Li, Xiang-Pei Li, Xiao-Mei Li, Guo-Sheng Wang, Yan Ma, Shu-Shan Zhao, Song-Guo Zheng

    To investigate the level of FOXP3 expressed in CD4+ CD39+ T cells in peripheral blood of patients with systemic lupus erythematosus (SLE) and observe the regulation of glucocorticoid on it. Frequencies of CD4+ CD25+ CD39+, CD4 CD25+ FOXP3+ and CD4+ CD39+ FOXP3+ T cells and levels of FOXP3 protein were analyzed by flow cytometry of 47 SLE patients (including 29 untreated/active SLE) and 22 healthy controls. Meanwhile, correlations among three groups and influences of glucocorticoid were analyzed. Percents of CD4+ CD25+ CD39+ T cells expressed in active SLE, inactive SLE and healthy controls were (1.3 +/- 0.5)%, (1.9 +/- 0.8)% and (2.3 +/- 1.0)% respectively, the level decreased in active SLE compared with inactive SLE and healthy controls P < 0.05 in each group, but it had no significant difference between the latter two groups (P > 0.05). In active SLE, levels of FOXP3 protein expressed in CD4+ CD25+, CD4+ CD25high and CD4+ CD39+ T cells were (45 +/- 12)%, (65 +/- 14)% and (70 +/- 14)% respectively. Levels of FOXP3 expressed in CD4+ CD25high and CD4+ CD39+ T cells were higher than that expressed in CD4+ CD25+ T cells (P < 0.01), while it had no significant difference between CD4 CD25high T cells and CD4+ CD39+ T cells (P > 0.05). These results demonstrate that CD39 may be a better surface marker of regulatory T cells, and that deficiency of CD39+ Treg cells may play an important role in the pathogenesis of SLE.


    • 18 September 2007
      • Vol. 87  (35) , 2505-7

    [Immunopathology of labial glands of patients with primary Sjögren's syndrome].

    by Xiao-Qiu Wang, Xiao-Mei Li, Xiang-Pei Li, Long Qian, Guo-Sheng Wang, Ke Chen, Yi-Ping Wang

    To investigate the expression of CD4+CD25+ regulatory T cell (Treg) in labial gland (SG) of the patients with Sjögren's syndrome (SS). Specimens of labial gland were obtained from 25 primary SS patients and 6 healthy controls during biopsy to be made into serial sections. Immunohistochemistry was used to examine the expression of CD25, CD4, CD8, CD68 and Foxp3. Infiltration of a great amount of mononuclear cells and atrophy of part of the labial glands were seen in the specimens from SS patients. The percentage of CD4+ T cells in the infiltrating leucocytes of the SS patients was (44.2 +/- 20.5)%, significantly higher than that of the controls [(9.2 +/- 6.0)%, P < 0.01]. CD25 and Foxp3 were completely absent in the specimens from both the controls and SS patients. CD4+CD25+ regulatory T cell lacks in the labial gland of SS patients. CD4+CD25+ regulatory T cells play a key role in the progression of SS.

    • 1 July 2007
      • Vol. 46  (7) , 544-6

    [Expression of forkhead box protein P3 in peripheral blood and salivary gland of patients with Sjogren's syndrome].

    by Xiao-Mei Li, Xiang-Pei Li, Long Qian, Guo-Sheng Wang, Hong Zhang, Xiao-Qiu Wang, Ke Chen, Yi-Ping Wang

    To investigate the expression of forkhead box protein P3 (Foxp3) in the peripheral blood and salivary gland of patients with Sjogren's Syndrome (SS). Reverse transcription polymerase chain reaction (RT-PCR) was used to examine Foxp3mRNA expression in the CD(4)(+) T cells and the salivary glands from 6 primary SS patients and 6 normal controls. Serial sections of biopsied salivary gland (SG) were examined with immunohistochemistry, using monoclonal mouse anti-human CD(4) and Foxp3 in 6 healthy controls and 31 primary SS patients. Significant difference in the number of infiltrating CD(4)(+) T cells was noted in the salivary glands of the patients and controls, but Foxp3(+)CD(4)(+) T cells were almost absent in those biopsy samples. Foxp3mRNA expression in the blood of SS patients was significantly lower than that in normal controls (0.21 +/- 0.17 vs 1.32 +/- 0.38, P < 0.0184). Foxp3mRNA expression was not detectable in the tissue of the salivary glands (n = 6). The absence of Foxp3(+)CD(4)(+) T cells in salivary glands with reduction of Foxp3mRNA expression in peripheral blood suggests an important role of Foxp3 in the pathogenesis of SS.

    • 17 April 2007
      • Vol. 87  (15) , 1034-6

    [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].

    by Xiao-Mei Li, Xiang-Pei Li, Long Qian, Guo-Sheng Wang, Hong Zhang, Zhi-Min Zhei, Qing Li, Ke Chen, Xiao-Qiu Wang, Yi-Ping Wang

    To investigate the expression of CD(4)(+) CD(25)(+) regulatory T cells (Tregs) in the peripheral blood and salivary gland of patients with primary Sjögren's syndrome (pSS). Samples of peripheral venous blood were collected from 57 newly diagnosed pSS patients, 1 male and 56 females, aged 47 (20 approximately 76), and 46 healthy controls. The levels of CD(4)(+) CD(25)(+) T regulatory cells and CD(4)(+) CD(25)(high) T regulatory cells in the peripheral blood were measured by flow-cytometric assay. Biopsy specimens of labial gland were collected from the 57 patients and 6 healthy person or patients with labial gland cyst. Pathological examination was conducted by light microscopy. Immunohistochemistry was conducted, by using monoclonal mouse anti-human to detect the expression of CD25, CD4, CD8, and CD68. Western blotting was used to detect the levels of IgG, IgM, and IgA. The salivary flow rate was measured. Schirmer's test was used to measure the tear flow rate. The level of CD(4)(+) CD(25)(+) Tregs in the blood of pSS patients was 6.9% (2.84% - 13.50%), significantly lower than that of the healthy controls [10.9% (5.77% - 15.3%), P < 0.001). The level of CD(4)(+) CD(25)(high) Tregs the blood of pSS patients was 0.6% (0.001% - 1.83%), significantly lower than that of the healthy controls [1.1% (0.13% - 2.45%), P < 0.001]. Immunohistochemistry showed that most of the infiltrating lymphocytes in the labial gland of the pSS patients were CD(4)(+) T cells, and there was no CD(25)(+) T cell in both groups. The numbers of peripheral CD(4)(+) CD(25)(+) T cells and CD(4)(+) CD(25)(high) Tregs in the pSS patients were not correlated with the tear flow rate, salivary flow rate, anti-SS-A/SS-B antibodies, and immunoglobulin level. The pSS patients show an absence of CD(4)(+) CD(25)(+) T cell in the labial gland of pSS patients, and reduction of the numbers of CD(4)(+) CD(25)(+) and CD(4)(+) CD(25)(high) Tregs in the peripheral blood, which suggests that Tregs play an important role in the pathogenesis of salivary gland destruction in SS.